FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000320645> ?p ?o ?g. }

• W2000320645 endingPage "47" @default.
• W2000320645 startingPage "41" @default.
• W2000320645 abstract "Current clinical studies support the role of neoadjuvant cisplatin administration prior to curative radiotherapy or radio-chemotherapy for advanced head and neck cancer. Nevertheless, based on locoregional control rates the studies indicate that there is need to redesign cisplatin-based schedules for induction chemotherapy, thus the ideal treatment regimen is yet to be established. While the pharmacokinetics/dynamics of daily cisplatin regimens correspond better with the cell cycle properties of head and neck cancers, weekly regimens are more commonly employed in clinics due to lower complications. Yet, the high rates of adverse events induced by current cisplatin schedules often represent a limiting factor in the overall success of the treatment. The aim of the present paper was to model the pharmacodynamic properties of cisplatin and to simulate and compare various neoadjuvant treatment regimens in regards to their effect on tumour control. Treatment simulation was undertaken on a virtual squamous cell carcinoma of the head and neck, previously grown by computer-based probabilistic methods. The model suggests that a novel cisplatin treatment, given every three days is comparable, in regards to tumour control, with the daily administration and more effective than the weekly regimen in neoadjuvant settings. Endpoints were assessed in terms of cell population regrowth after treatment cessation followed by two weeks of unperturbed growth. Simulation of two weeks low-dose daily cisplatin followed by two weeks ‘free growth’ lead to 15% population regrowth, while weekly high-dose cisplatin over three weeks, followed by two weeks unperturbed growth resulted in 52% tumour cell regrowth. The proposed novel schedule of low-dose third-daily cisplatin gives closer tumour regrowth to daily administration (27% versus 15%) than to the weekly regimen (52%) and also similar cell distribution along the cell cycle as the daily one, suggesting therefore comparable response to subsequent treatment. The advantage of using a third-daily drug regimen would be a decrease in normal tissue complication rates compared to daily administration and possibly an increase in tumour control when compared to the ‘conventional’ weekly cisplatin delivery." @default.
• W2000320645 created "2016-06-24" @default.
• W2000320645 creator A5009380500 @default.
• W2000320645 creator A5027460327 @default.
• W2000320645 date "2012-03-01" @default.
• W2000320645 modified "2023-09-23" @default.
• W2000320645 title "Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio" @default.
• W2000320645 cites W1784479792 @default.
• W2000320645 cites W1975162134 @default.
• W2000320645 cites W1993384565 @default.
• W2000320645 cites W1996594688 @default.
• W2000320645 cites W1998939814 @default.
• W2000320645 cites W2010906774 @default.
• W2000320645 cites W2014166989 @default.
• W2000320645 cites W2022095987 @default.
• W2000320645 cites W2022302560 @default.
• W2000320645 cites W2039368876 @default.
• W2000320645 cites W2056118025 @default.
• W2000320645 cites W2056549760 @default.
• W2000320645 cites W2057592493 @default.
• W2000320645 cites W2059784012 @default.
• W2000320645 cites W2060861961 @default.
• W2000320645 cites W2071207166 @default.
• W2000320645 cites W2071239103 @default.
• W2000320645 cites W2075618378 @default.
• W2000320645 cites W2085101245 @default.
• W2000320645 cites W2089257078 @default.
• W2000320645 cites W2094974235 @default.
• W2000320645 cites W2137178561 @default.
• W2000320645 cites W2150335546 @default.
• W2000320645 cites W2152799577 @default.
• W2000320645 cites W2155115544 @default.
• W2000320645 cites W612414919 @default.
• W2000320645 doi "https://doi.org/10.1016/j.jtbi.2011.12.001" @default.
• W2000320645 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22182756" @default.
• W2000320645 hasPublicationYear "2012" @default.
• W2000320645 type Work @default.
• W2000320645 sameAs 2000320645 @default.
• W2000320645 citedByCount "7" @default.
• W2000320645 countsByYear W20003206452012 @default.
• W2000320645 countsByYear W20003206452013 @default.
• W2000320645 countsByYear W20003206452014 @default.
• W2000320645 countsByYear W20003206452015 @default.
• W2000320645 countsByYear W20003206452020 @default.
• W2000320645 countsByYear W20003206452021 @default.
• W2000320645 crossrefType "journal-article" @default.
• W2000320645 hasAuthorship W2000320645A5009380500 @default.
• W2000320645 hasAuthorship W2000320645A5027460327 @default.
• W2000320645 hasConcept C121608353 @default.
• W2000320645 hasConcept C126322002 @default.
• W2000320645 hasConcept C141071460 @default.
• W2000320645 hasConcept C143998085 @default.
• W2000320645 hasConcept C197934379 @default.
• W2000320645 hasConcept C2776530083 @default.
• W2000320645 hasConcept C2776694085 @default.
• W2000320645 hasConcept C2776833033 @default.
• W2000320645 hasConcept C2778239845 @default.
• W2000320645 hasConcept C2778292576 @default.
• W2000320645 hasConcept C2781413609 @default.
• W2000320645 hasConcept C2908647359 @default.
• W2000320645 hasConcept C509974204 @default.
• W2000320645 hasConcept C530470458 @default.
• W2000320645 hasConcept C71924100 @default.
• W2000320645 hasConcept C99454951 @default.
• W2000320645 hasConceptScore W2000320645C121608353 @default.
• W2000320645 hasConceptScore W2000320645C126322002 @default.
• W2000320645 hasConceptScore W2000320645C141071460 @default.
• W2000320645 hasConceptScore W2000320645C143998085 @default.
• W2000320645 hasConceptScore W2000320645C197934379 @default.
• W2000320645 hasConceptScore W2000320645C2776530083 @default.
• W2000320645 hasConceptScore W2000320645C2776694085 @default.
• W2000320645 hasConceptScore W2000320645C2776833033 @default.
• W2000320645 hasConceptScore W2000320645C2778239845 @default.
• W2000320645 hasConceptScore W2000320645C2778292576 @default.
• W2000320645 hasConceptScore W2000320645C2781413609 @default.
• W2000320645 hasConceptScore W2000320645C2908647359 @default.
• W2000320645 hasConceptScore W2000320645C509974204 @default.
• W2000320645 hasConceptScore W2000320645C530470458 @default.
• W2000320645 hasConceptScore W2000320645C71924100 @default.
• W2000320645 hasConceptScore W2000320645C99454951 @default.
• W2000320645 hasLocation W20003206451 @default.
• W2000320645 hasLocation W20003206452 @default.
• W2000320645 hasOpenAccess W2000320645 @default.
• W2000320645 hasPrimaryLocation W20003206451 @default.
• W2000320645 hasRelatedWork W2031206533 @default.
• W2000320645 hasRelatedWork W2313027913 @default.
• W2000320645 hasRelatedWork W2349270370 @default.
• W2000320645 hasRelatedWork W2404042595 @default.
• W2000320645 hasRelatedWork W2414041517 @default.
• W2000320645 hasRelatedWork W2460868461 @default.
• W2000320645 hasRelatedWork W3021135223 @default.
• W2000320645 hasRelatedWork W3138836845 @default.
• W2000320645 hasRelatedWork W61870694 @default.
• W2000320645 hasRelatedWork W757206253 @default.
• W2000320645 hasVolume "297" @default.
• W2000320645 isParatext "false" @default.
• W2000320645 isRetracted "false" @default.
• W2000320645 magId "2000320645" @default.

• next